GSK_ Annual_Report_2021-22

171 (Pursuant to first proviso to sub-section (3) of section 129 read with rule 5 of Companies (Accounts) Rules, 2014) Part "A": Subsidiaries (Information in respect of each subsidiary to be presented with amounts in ` lakhs) 1. Name of the subsidiary: Biddle Sawyer Limited 2. Reporting period for the subsidiary concerned, if different from the holding company's reporting period: Same Reporting period as of Holding Company 3. Reporting currency and Exchange rate as on the last date of the relevant financial year in the case of foreign subsidiaries: NA 4. Share capital: 96.00 5. Reserves & surplus: 8,87.51 6. Total assets: 53,95.58 7. Total Liabilities: 44,12.07 8. Investments: Nil 9. Turnover: 80,82.46 10. Profit before taxation: 5,60.48 11. Provision for taxation: 1,41.13 12. Profit after taxation: 4,19.35 13. Proposed Dividend: Nil 14. % of shareholding: 100% Notes: The following information shall be furnished at the end of the statement: Not Applicable 1. Names of subsidiaries which are yet to commence operations NA 2. Names of subsidiaries which have been liquidated or sold during the year. NA Part "B": Associates and Joint Ventures Not Applicable Form No. Aoc.1 Statement containing salient features of the financial statement of subsidiaries/associate companies/joint ventures